CAM
BHVN

Carret Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Carret Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,407
Closed -$213K – 276
2022
Q3 		$213K Sell
1,407
-276
-16% -$40.9K 0.03% 249
2022
Q2 		$245K Buy
+1,683
New +$215K 0.03% 244
2022
Q1 		– Sell
-1,683
Closed -$232K – 305
2021
Q4 		$232K Hold
1,683
– – 0.03% 273
2021
Q3 		$234K Buy
+1,683
New +$210K 0.03% 263

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Carret Asset Management's BHVN Position: Q4 2022 in Review

Carret Asset Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 1,407 shares — an estimated $213K sold.

Carret Asset Management first reported a position in BHVN in Q3 2021 and held it in 4 quarters. The position peaked at $245K in Q2 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Carret Asset Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Carret Asset Management sold 1,407 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $213K.
  • Carret Asset Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2021 and held it in 4 quarters.
  • Carret Asset Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $245K in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Carret Asset Management's 13F filing for Q4 2022, filed 10 Jan 2023.